Cancer category | Intellectual disabilities | General population | SMR (95% CI) | ||||
N | % | CMR | N | % | CMR | ||
Number of underlying cause cancer deaths | 223 | 100.0 | 291.2 | 9537 | 100.0 | 431.7 | 1.07 (0.92 to 1.24) |
Digestive organs | 68 | 30.5 | 88.8 | 2599 | 27.3 | 117.6 | 1.15 (0.88 to 1.50) |
Colorectal | 32 | 14.3 | 41.8 | 895 | 9.4 | 40.5 | 1.59 (1.08 to 2.33) |
Oesophageal | 15 | 6.7 | 19.6 u | 531 | 5.6 | 24.0 | 1.19 (0.67 to 2.13) u |
Stomach | 9 | 4.0 | 11.8 u | 332 | 3.5 | 15.0 | 1.23 (0.60 to 2.53) u |
Pancreas | 7 | 3.1 | 9.1 u | 389 | 4.1 | 17.6 | 0.85 (0.38 to 1.94) u |
Liver | <5 | 328 | 3.4 | 14.9 | |||
Respiratory and intrathoracic organs | 36 | 16.1 | 47 | 2344 | 24.6 | 106.1 | 0.71 (0.49 to 1.01) |
Lung | 32 | 14.3 | 41.8 | 2231 | 23.4 | 101.0 | 0.66 (0.45 to 0.97) |
Metastatic cancer of unknown primary origin | 21 | 9.7 | 27.4 | 327 | 3.4 | 14.8 | 2.84 (1.76 to 4.58) |
Urinary tract | 14 | 6.3 | 18.3 u | 510 | 5.3 | 23.1 | 0.95 (0.54 to 1.66) u |
Kidney | 8 | 3.6 | 10.5 u | 180 | 1.9 | 8.2 | 1.38 (0.66 to 2.90) u |
Bladder | 5 | 2.2 | 6.5 u | 277 | 2.9 | 12.5 | 0.71 (0.28 to 1.80) u |
Haematopoietic | 15 | 6.7 | 19.6 u | 539 | 5.7 | 24.4 | 1.26 (0.71 to 2.23) u |
Hodgkin’s and non-Hodgkin’s lymphoma | 6 | 2.7 | 7.8 u | 219 | 2.3 | 9.9 | 1.09 (0.47 to 2.52) u |
Lymphoid leukaemia | <5 | 49 | 0.5 | 2.2 | |||
Myeloid leukaemia | <5 | 91 | 1.0 | 4.1 | |||
Leukaemia of unspecified cell type | <5 | <5 | |||||
Male genital organs | 12 | 5.4 | 15.7 u | 767 | 8.0 | 34.8 | 1.10 (0.60 to 2.01) u |
Prostate | 10 | 4.5 | 13.1 u | 741 | 7.8 | 33.6 | 0.97 (0.51 to 1.87) u |
Testicular | <5 | 9 | 10.0 | 0.4 u | |||
Lip, oral cavity and pharynx | 6 | 2.7 | 7.8 u | 256 | 2.7 | 11.6 | 0.79 (0.34 to 1.86) u |
Central nervous system | <5 | 215 | 2.3 | 9.7 | |||
Mesothelial and soft tissue | <5 | 186 | 2.0 | 8.4 | |||
Melanoma (skin) | <5 | 88 | 0.9 | 4 | |||
Non-melanoma skin | <5 | 466 | 0.2 | 21.1 | |||
Thyroid and other endocrine glands | <5 | 12 | 0.1 | 0.5 u | |||
Thyroid | <5 | 6 | 0.1% | 0.3 u | |||
Bone and articular cartilage | <5 | 14 | 0.1% | 0.6 u |
Non-melanoma skin cancers were not included in the rate calculations in the denominator. Figures in bold are statistically significant at 5% level.
CMR are reported per 100 000 person-years and SMR are age-standardised rate ratios.
U, unreliable age–sex-standardisation due to n<20 cases.